As consumer technology continues to advance, wearable or portable smart devices are becoming increasingly accessible, contributing to the rapid emergence of digital biomarkers in modern healthcare, as well as a...
Read More
The finger tap test is one of the oldest and most widely used motor assessments in clinical neuroscience. A clinician watches a patient tap as quickly as possible for a...
Read More
Healthcare systems worldwide are increasingly shifting toward data-driven models integrated with digital health technologies (DHTs) and artificial intelligence (AI). This shift is reflected in the rapid growth of the global...
Read More
Introduction The adoption of digital biomarkers in clinical trials is accelerating rapidly, driven by wearable sensors, decentralized trial models, and the demand for continuous patient monitoring. As sponsors increasingly explore...
Read More
Inclusion across leading analyses reflects growing adoption of digital biomarkers and growing need for more rigorous measurement strategies in clinical development New York, NY — March 17, 2026 —...
Read More
“Rare” diseases are something of a misnomer: about 30 million Americans, half of them children, have a rare disease – and 90% have no approved treatments at all. The need…
NEW YORK– (BUSINESS WIRE) — Koneksa, the evidence-based digital biomarkers company, announced today an extended partnership with SSI Strategy, a life sciences consulting firm, that will provide both organizations with...
Read More
At the recent CNS Summit – an annual gathering of R&D life science leaders that has taken place since 2009 – Koneksa was proud to sit down with some of…
Using data from digital health technologies is making it possible to measure the performance of investigational treatments more rapidly, completely, and accurately than ever before. What’s a digital biomarker?Biomarkers are,…
